These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 10496023

  • 1. [Mechanisms of drug resistance of two cell lines of human chronic promyelocytic leukemia K562, resistant to DNA topoisomerase II inhibitors adriamycin and etoposide].
    Meliksetian MB, Berezkina EV, Pavlenko MA, Grinchuk TM.
    Tsitologiia; 1999; 41(7):615-21. PubMed ID: 10496023
    [Abstract] [Full Text] [Related]

  • 2. Reduced expression of DNA topoisomerase II confers resistance to etoposide (VP-16) in small cell lung cancer cell lines established from a refractory tumor of a patient and by in vitro selection.
    Andoh T, Nishizawa M, Hida T, Ariyoshi Y, Takahashi T, Ueda R.
    Oncol Res; 1996; 8(6):229-38. PubMed ID: 8895198
    [Abstract] [Full Text] [Related]

  • 3. Differential induction of etoposide-mediated apoptosis in human leukemia HL-60 and K562 cells.
    Ritke MK, Rusnak JM, Lazo JS, Allan WP, Dive C, Heer S, Yalowich JC.
    Mol Pharmacol; 1994 Oct; 46(4):605-11. PubMed ID: 7969039
    [Abstract] [Full Text] [Related]

  • 4. Complex response of breast epithelial cell lines to topoisomerase inhibitors.
    Davis PL, Shaiu WL, Scott GL, Iglehart JD, Hsieh TS, Marks JR.
    Anticancer Res; 1998 Oct; 18(4C):2919-32. PubMed ID: 9713486
    [Abstract] [Full Text] [Related]

  • 5. Human melanoma cell lines selected in vitro displaying various levels of drug resistance against cisplatin, fotemustine, vindesine or etoposide: modulation of proto-oncogene expression.
    Kern MA, Helmbach H, Artuc M, Karmann D, Jurgovsky K, Schadendorf D.
    Anticancer Res; 1997 Oct; 17(6D):4359-70. PubMed ID: 9494534
    [Abstract] [Full Text] [Related]

  • 6. DNA topoisomerase II alpha gene expression under transcriptional control in etoposide/teniposide-resistant human cancer cells.
    Kubo T, Kohno K, Ohga T, Taniguchi K, Kawanami K, Wada M, Kuwano M.
    Cancer Res; 1995 Sep 01; 55(17):3860-4. PubMed ID: 7641205
    [Abstract] [Full Text] [Related]

  • 7. Reduced phosphorylation of topoisomerase II in etoposide-resistant human leukemia K562 cells.
    Ritke MK, Allan WP, Fattman C, Gunduz NN, Yalowich JC.
    Mol Pharmacol; 1994 Jul 01; 46(1):58-66. PubMed ID: 8058057
    [Abstract] [Full Text] [Related]

  • 8. GCS induces multidrug resistance by regulating apoptosis-related genes in K562/AO2 cell line.
    Liu Y, Xie KM, Yang GQ, Bai XM, Shi YP, Mu HJ, Qiao WZ, Zhang B, Xie P.
    Cancer Chemother Pharmacol; 2010 Aug 01; 66(3):433-9. PubMed ID: 19936984
    [Abstract] [Full Text] [Related]

  • 9. Overexpression of Bax gene sensitizes K562 erythroleukemia cells to apoptosis induced by selective chemotherapeutic agents.
    Kobayashi T, Ruan S, Clodi K, Kliche KO, Shiku H, Andreeff M, Zhang W.
    Oncogene; 1998 Mar 26; 16(12):1587-91. PubMed ID: 9569026
    [Abstract] [Full Text] [Related]

  • 10. Adenovirus-mediated human topoisomerase IIalpha gene transfer increases the sensitivity of etoposide-resistant human and mouse breast cancer cells.
    Asano T, Kleinerman ES, Zwelling LA, Zhou Z, Fukunaga Y.
    Acta Oncol; 2005 Mar 26; 44(3):240-7. PubMed ID: 16076696
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of apoptotic proteins causes multidrug resistance in renal carcinoma cells.
    Scheltema JM, Romijn JC, van Steenbrugge GJ, Schröder FH, Mickisch GH.
    Anticancer Res; 2001 Mar 26; 21(5):3161-6. PubMed ID: 11848468
    [Abstract] [Full Text] [Related]

  • 12. Multidrug resistance due to impaired DNA cleavage in a VP-16-resistant human leukemia cell line.
    Fukushima T, Takemura H, Yamashita T, Ishisaka T, Inai K, Imamura S, Urasaki Y, Ueda T.
    Anticancer Res; 1999 Mar 26; 19(6B):5111-5. PubMed ID: 10697518
    [Abstract] [Full Text] [Related]

  • 13. Hypophosphorylation of topoisomerase II in etoposide (VP-16)-resistant human leukemia K562 cells associated with reduced levels of beta II protein kinase C.
    Ritke MK, Murray NR, Allan WP, Fields AP, Yalowich JC.
    Mol Pharmacol; 1995 Nov 26; 48(5):798-805. PubMed ID: 7476909
    [Abstract] [Full Text] [Related]

  • 14. Relationship of DNA topoisomerase II alpha and beta expression to cytotoxicity of antineoplastic agents in human acute lymphoblastic leukemia cell lines.
    Brown GA, McPherson JP, Gu L, Hedley DW, Toso R, Deuchars KL, Freedman MH, Goldenberg GJ.
    Cancer Res; 1995 Jan 01; 55(1):78-82. PubMed ID: 7805045
    [Abstract] [Full Text] [Related]

  • 15. Increased phosphorylation of DNA topoisomerase II in etoposide-resistant mutants of human cancer KB cells.
    Takano H, Kohno K, Ono M, Uchida Y, Kuwano M.
    Cancer Res; 1991 Aug 01; 51(15):3951-7. PubMed ID: 1649696
    [Abstract] [Full Text] [Related]

  • 16. Altered topoisomerase IIalpha and multidrug resistance-associated protein levels during drug selection: adaptations to increasing drug pressure.
    Matsumoto Y, Takano H, Nagao S, Fojo T.
    Jpn J Cancer Res; 2001 Sep 01; 92(9):968-74. PubMed ID: 11572765
    [Abstract] [Full Text] [Related]

  • 17. Selection of human leukemic CEM cells for resistance to the DNA topoisomerase II catalytic inhibitor ICRF-187 results in increased levels of topoisomerase IIalpha and altered G(2)/M checkpoint and apoptotic responses.
    Morgan SE, Cadena RS, Raimondi SC, Beck WT.
    Mol Pharmacol; 2000 Feb 01; 57(2):296-307. PubMed ID: 10648639
    [Abstract] [Full Text] [Related]

  • 18. Overexpression of sorcin in multidrug resistant human leukemia cells and its role in regulating cell apoptosis.
    Qi J, Liu N, Zhou Y, Tan Y, Cheng Y, Yang C, Zhu Z, Xiong D.
    Biochem Biophys Res Commun; 2006 Oct 13; 349(1):303-9. PubMed ID: 16934756
    [Abstract] [Full Text] [Related]

  • 19. Alterations in mRNA expression of apoptosis-related genes BCL2, BAX, FAS, caspase-3, and the novel member BCL2L12 after treatment of human leukemic cell line HL60 with the antineoplastic agent etoposide.
    Floros KV, Thomadaki H, Florou D, Talieri M, Scorilas A.
    Ann N Y Acad Sci; 2006 Dec 13; 1090():89-97. PubMed ID: 17384250
    [Abstract] [Full Text] [Related]

  • 20. DNA topoisomerase II inhibitor, etoposide, induces p21WAF1/CIP1 through down-regulation of c-Myc in K562 cells.
    Horiguchi-Yamada J, Fukumi S, Saito S, Nakayama R, Iwase S, Yamada H.
    Anticancer Res; 2002 Dec 13; 22(6C):3827-32. PubMed ID: 12553001
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.